Sang‐Uk Han
한양대학교 의과대학 생화학·분자생물학교실 · 의학
Sang-Uk Han 교수의 연구실은 위암을 비롯한 암의 대사 변화와 생물학적 기전을 규명하는 데 초점을 맞추고 있으며, 특히 유기산 대사 프로파일링과 혈중 혼합성장인자(HGF) 농도 변화를 통해 암의 진행 상황을 생물학적 지표로 활용하고자 합니다. 또한 수술적 치료 결과의 안정성과 장기 예후에 대한 분석을 통해 위암 치료 전략의 최적화를 도모하고 있습니다. 최근에는 산업화된 건설 공정에서의 품질 향상을 위해 증강현실(AR) 기반의 시각화 및 정위 등록 기술을 개발하여 건축·설비 관리 분야에 응용하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
ClinicalTrials.gov Identifier: NCT01456598.
The levels of organic acids representing metabolic pathway end products are important indicators of physiological status, and may be associated with metabolic changes in cancer. The aim of this study is to investigate the levels of organic acids in cancerous and normal tissues from gastric cancer patients and to confirm the role of metabolic alterations in gastric carcinogenesis. Organic acids in normal and cancerous tissues from forty-five patients with gastric adenocarcinoma were investigated
After balancing covariates, RG demonstrated reliable surgical outcomes from the beginning. Long-term survival after RG and LG for GC was similar.
Product quality is recognized as a major benefit in industrialized construction because of the utilization of machines in manufacturing facilities. However, manual work continues to exist in complex assembly projects, which can potentially cause quality issues. To address such quality issues in industrialized manufacturing processes, projection-based augmented reality (AR) techniques have been applied in other industries (e.g., manufacturing), but on a smaller scale and at a short distance. To a
Augmented reality can improve construction and facility management by visualizing an as-planned model on its corresponding surface for fast, easy, and correct information retrieval. This requires the localization registration of an as-built model in an as-planned model. However, the localization and registration of indoor environments fail, owing to self-similarity in an indoor environment, relatively large as-planned models, and the presence of additional unplanned objects. Therefore, this pape
Hepatocyte growth factor (HGF) can promote proliferation of many types of tumor cells including gastric cancer cells. To study the role of HGF in the progression of gastric carcinoma, HGF levels were measured by an enzyme immunoassay (EIA) system in sera of gastric cancer patients and followed up the levels after the operation. The mean serum HGF level in 212 healthy control subjects, 140 patients with primary gastric cancer, and 13 patients with recurrent gastric cancer were 0.199 +/- 0.073, 0.
